Kissei Pharmaceutical Co., Ltd.
Records under this name other than the patents Kissei Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 24 patents it holds.
Back to Kissei Pharmaceutical Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,354,382 | Hemifumarate of a pyrazole derivative Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,077,297 | Fc fusion high affinity IgE receptor α-chain Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,604,779 | Method for production of mutant-type human erythropoietin Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,683,355 | Genetically-Modified Cells and Method for Producing Same Formerly held In force · High confidence | In force | High confidence | |
| US 11,596,644 | Method for Treating Post-Prandial Hypoglycemia Formerly held In force · High confidence | In force | High confidence | |
| US 8,829,040 | (AZA)INDOLE Derivative and Use Thereof for Medical Purposes Lapsed on the fee record Ended Sep 9, 2026 · High confidence | Lapsed on the fee record | Ended Sep 9, 2026 | High confidence |
| US 8,748,452 | Indolizine derivative and use thereof for medical purposes Lapsed on the fee record Ended Jun 10, 2026 · USPTO record | Lapsed on the fee record | Ended Jun 10, 2026 | USPTO record |
| US 8,466,152 | (AZA)INDOLE Derivative and Use Thereof for Medical Purposes No holder on record Lapsed on the fee record Ended Jun 18, 2025 · Medium confidence | Lapsed on the fee record | Ended Jun 18, 2025 | Medium confidence |
| US 10,995,084 | Pyrrolidine derivative Lapsed on the fee record Ended May 4, 2025 · USPTO record | Lapsed on the fee record | Ended May 4, 2025 | USPTO record |
| US 9,585,885 | Substituted pyrido[2,3-g]quinazolines as dopamine D2 receptor agonists Lapsed on the fee record Ended Mar 7, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 7, 2025 | USPTO record |